Synopsys stock rating downgraded by Rosenblatt on IP business weakness

Synopsys (SNPS) was downgraded by Rosenblatt to Neutral with a reduced price target of $605, citing weaker-than-expected performance in its IP business, which contributed to Q3 revenues of $1.74 billion and EPS of $3.39 falling below analyst expectations. The company, trading at a high 68.9x P/E, attributed its underperformance to factors including China export restrictions and IP product missteps, prompting a planned 10% workforce reduction and a strategic pivot of its IP product roadmap. While analyst reactions were mixed, with some maintaining positive ratings, others like Baird also downgraded due to Design IP outlook concerns, reflecting a divergent view on Synopsys's future growth prospects amidst its strategic adjustments.

Analysis

Synopsys (SNPS) is facing significant headwinds centered on its Intellectual Property (IP) business, which drove a third-quarter revenue miss with reported sales of $1.74 billion against a $1.77 billion consensus. The IP segment's revenue contribution has declined to 25% from 31% in fiscal 2024, a shortfall attributed to China export restrictions, customer-side delays at a major foundry, and internal product strategy missteps. This has prompted a mixed but predominantly cautious reaction from analysts, with Rosenblatt and Baird downgrading the stock to Neutral while others maintained positive ratings but lowered price targets. In response, management is initiating a 10% workforce reduction and a strategic portfolio review to pivot the IP roadmap toward higher-growth areas and improve margins. Despite an impressive gross profit margin of 81.13% and a strong 23% year-over-year growth in its design automation segment, the company's premium valuation, evidenced by a 68.9x P/E ratio, is now under scrutiny, as the market weighs whether these corrective actions can offset the IP division's weakness and justify its current trading levels.

Key Decisions for Investors

• Given the stock's high 68.9x P/E ratio and recent earnings miss, investors should re-evaluate if the premium valuation is sustainable amid growing concerns over the core IP business.
• Monitor the IP segment's revenue contribution and growth in subsequent quarters, as a failure to execute the strategic pivot could validate concerns about rising competition and lead to further downside.
• Investors should weigh the pronounced weakness in the IP segment against the reported strength in the design automation business, which grew 23% YoY, as this performance divergence is critical to the overall investment thesis.
• Track the impact of the 10% workforce reduction on both operating margin improvement and any potential disruption to innovation, particularly concerning the integration of the Ansys acquisition.